1. Home
  2. QRVO vs RGEN Comparison

QRVO vs RGEN Comparison

Compare QRVO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Qorvo Inc.

QRVO

Qorvo Inc.

HOLD

Current Price

$86.90

Market Cap

8.1B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$169.53

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QRVO
RGEN
Founded
1957
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
8.2B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
QRVO
RGEN
Price
$86.90
$169.53
Analyst Decision
Hold
Buy
Analyst Count
14
10
Target Price
$98.23
$174.90
AVG Volume (30 Days)
882.5K
552.2K
Earning Date
01-27-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.30
0.03
Revenue
$3,663,072,000.00
$707,890,000.00
Revenue This Year
$3.36
$17.84
Revenue Next Year
$2.39
$12.44
P/E Ratio
$37.54
$6,458.78
Revenue Growth
N/A
11.74
52 Week Low
$49.46
$102.97
52 Week High
$106.30
$182.52

Technical Indicators

Market Signals
Indicator
QRVO
RGEN
Relative Strength Index (RSI) 51.48 61.59
Support Level $84.50 $162.21
Resistance Level $87.50 $167.65
Average True Range (ATR) 1.56 4.64
MACD 0.00 0.14
Stochastic Oscillator 52.69 90.85

Price Performance

Historical Comparison
QRVO
RGEN

About QRVO Qorvo Inc.

Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: